Results 131 to 140 of about 713,984 (284)

Compiling mortality statistics from civil registration systems in Viet Nam: the long road ahead

open access: yesBulletin of the World Health Organization, 2010
Accurate mortality statistics, needed for population health assessment, health policy and research, are best derived from data in vital registration systems.
Chalapati Rao   +5 more
doaj  

Counting the dead and what they died from: an assessment of the global status of cause of death data

open access: yesBulletin of the World Health Organization
OBJECTIVE: We sought to assess the current status of global data on death registration and to examine several indicators of data completeness and quality. METHODS: We summarized the availability of death registration data by year and country.
Colin D. Mathers   +4 more
doaj   +1 more source

Evidence of Iron Accumulation in Cerebral Adrenoleukodystrophy: A Potential Novel Disease Mechanism

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT In this first application of Quantitative Susceptibility Mapping Source Separation to cerebral adrenoleukodystrophy, we uncovered alterations in iron and myelin within lesions and normal appearing white matter. As validation, we demonstrate abnormal iron accumulation in those same compartments within primary brain tissue.
Christina L. Nemeth   +8 more
wiley   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

DEATH REGISTRATION. [PDF]

open access: yesThe Lancet, 1893
openaire   +1 more source

Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

open access: yesArthritis Care &Research, EarlyView.
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla   +13 more
wiley   +1 more source

Preferences for post‐traumatic osteoarthritis prevention strategies in individuals with anterior cruciate ligament injury

open access: yesArthritis Care &Research, Accepted Article.
Objectives There is growing interest in evaluating new strategies to delay or prevent post‐traumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury.
Kevin Kennedy   +9 more
wiley   +1 more source

Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment

open access: yesArthritis Care &Research, EarlyView.
Objective Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to identify biomarkers of histologic features and treatment response.
Andrea Fava   +48 more
wiley   +1 more source

Estimation of Deaths in Under One-year Children in Mazandaran Province, North of Iran, using Hospital Information

open access: yesمجله اپیدمیولوژی ایران, 2018
Background and Objectives: The cause of death in children under one year can be an important tool for designing prevention strategies and reducing the mortality rate.
A Alipour, SA GHadiri, L Khazaei
doaj  

Home - About - Disclaimer - Privacy